Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 6Adenocarcinoma of Lung 4Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Rectal Neoplasms 1Piebaldism 1Lung Neoplasms 1Gastrointestinal Stromal Tumors 1Anatomic Stage IV Breast Cancer AJCC v8 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Paclitaxel 23Carboplatin 22Capecitabine 18Gemcitabine 16130-nm albumin-bound paclitaxel 16pembrolizumab 14Cyclophosphamide 12atezolizumab 9Epirubicin 9sacituzumab govitecan 8Albumin-Bound Paclitaxel 8eribulin 6Vinorelbine 6Drug Therapy 6Doxorubicin 6camrelizumab 4Docetaxel 4Cisplatin 4Injections 3pegfilgrastim 2olaparib 2famitinib 2Filgrastim 2Everolimus 2veliparib 1trilaciclib 1toripalimab 1taxane 1niraparib 1ipatasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Triple Negative Breast Neoplasms × Mastectomy, Segmental × Clear all
NCT01805076 2025-09-05

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
317 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡